Get the Stockscreener App
9.01
2.27%
0.20
After Hours:
9.05
0.04
+0.44%
Novavax Inc Stock (NVAX) Latest News
Novavax (NASDAQ:NVAX) Shares Down 5.7%Here's Why - MarketBeat
Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Nanopharmaceuticals Market Generated Opportunities, Future - openPR
Novavax, Inc. (NVAX) Stock: The Under-the-Radar Stock Poised for Massive Upside in 2025 - MSN
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Moderna stock rises following RFK Jr's comments - MSN
Moderna stock rises following RFK Jr's comments By Investing.com - Investing.com South Africa
Novavax (NASDAQ:NVAX) delivers shareholders strong 122% return over 1 year, surging 11% in the last week alone - Simply Wall St
Novavax falls after guidance cut on lower vaccine sales - MSN
Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Novavax, Inc. (NASDAQ:NVAX) is Shah Capital Management's 2nd Largest Position - MarketBeat
Novavax (XTER:NVV1) Short-Term Capital Lease Obligation : €9.68 Mil (As of Sep. 2024) - GuruFocus.com
Novavax (XTER:NVV1) Free Cash Flow : €-112.35 Mil (TTM As of Sep. 2024) - GuruFocus.com
Novavax (NASDAQ:NVAX) Shares Up 6.1%Here's Why - MarketBeat
Novavax Inc. stock underperforms Friday when compared to competitors - MarketWatch
Trump Administration Halts All Communications From The Centers For Disease Control As Bird Flu Spreads - Benzinga
Novavax call volume above normal and directionally bullish - TipRanks
Wall Street Analysts Predict an 81.61% Upside in Novavax (NVAX): Here's What You Should Know - Yahoo Finance
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Novavax, Inc. (NASDAQ:NVAX) Receives $17.83 Average PT from Analysts - MarketBeat
10 Under-the-Radar Stocks with Massive Upside for 2025 - Insider Monkey
Novavax climbs as FDA lifts clinical hold on Covid, flu combo trials - MSN
Analysts Set Novavax, Inc. (NASDAQ:NVAX) PT at $17.83 - MarketBeat
Retail Investors Bet On Anavex Lifesciences Stock To Outperform Novavax, Rigel Pharma In Q1 On Alzheimer’s Drug Buzz - MSN
Bird Flu Raising Red Flags Among Health Officials, CDC Urges Faster Testing - Benzinga
Moderna Dropped by 20% This Week -- Is It a Smart Buy Right Now? - The Motley Fool
Novavax Cashes In On Its COVID Albatross -- Challenges Remain (Rating Upgrade) - Seeking Alpha
Novavax (NVAX) Rises But Trails Market: What Investors Should Know - Yahoo Finance
Novavax Inc. stock underperforms Monday when compared to competitors - MarketWatch
Novavax Slips 7.3% After 2024 Revenue Guidance Reaffirmed - MarketWatch
Looking Into Novavax's Recent Short Interest - Benzinga
Why Novavax (NVAX) Stock Is Falling - Benzinga
Novavax: presents its 2025 growth strategy - Marketscreener.com
Novavax Shares Strategic Updates at Healthcare Conference - TipRanks
We Asked Retail If Novavax Stock Is A Buy At Current Levels: Nearly 70% Think It's Undervalued - MSN
Novavax to complete data submission to FDA by end of the year for authorization of its coronavirus vaccine - WPSD Local 6
(NVAX) On The My Stocks Page - Stock Traders Daily
Why Novavax Stock Is Volatile This Week - Benzinga
Novavax (NASDAQ:NVAX) Stock Price Down 8.2%Time to Sell? - MarketBeat
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies - Benzinga
Novavax, Inc. (NVAX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Novavax (NASDAQ:NVAX) surges 35% this week, taking five-year gains to 171% - Yahoo Finance
Strength Seen in Novavax (NVAX): Can Its 10.9% Jump Turn into More Strength? - MSN
Vaccine Stocks Jump After CDC Reports First US Bird-Flu Death - Yahoo Finance
Health Care Up as Vaccine Makers Surge -- Health Care Roundup - Marketscreener.com
Moderna, BioNTech, Novavax Surge After CDC Reports Two-Week Covid Spike - Yahoo! Voices
Options Alert: Why Novavax (NVAX) Could Be The Biotech Hero Of Trump 2.0 - Barchart
Novavax (NASDAQ:NVAX) Sees Large Volume IncreaseShould You Buy? - MarketBeat
Novavax Target of Unusually High Options Trading (NASDAQ:NVAX) - MarketBeat
Moderna, Novavax Stocks Climb Pre-Market On Growing Bird Flu Concerns: Retail Engagement Soars - MSN
US Records First Human Bird Flu Death, High Levels Of Respiratory Illnesses: Vaccine Stocks Rally - Benzinga
Novavax (NVAX) Shares Cross Above 200 DMA - Nasdaq
5.49%
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):